| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |